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Objective To quantify the extent to which cerebrospinal fluid (CSF) shunt revisions are associated with increased
risk of CSF shunt infection, after adjusting for patient factors that may contribute to infection risk.
Study designWe used the Hydrocephalus Clinical Research Network registry to assemble a large prospective 6-
center cohort of 1036 children undergoing initial CSF shunt placement between April 2008 and January 2012. The
primary outcome of interest was first CSF shunt infection. Data for initial CSF shunt placement and all subsequent
CSF shunt revisions prior to first CSF shunt infection, where applicable, were obtained. The risk of first infection was
estimated using a multivariable Cox proportional hazard model accounting for patient characteristics and CSF
shunt revisions, and is reported using hazard ratios (HRs) with 95% CI.
ResultsOf the 102 children who developed first infection within 12months of placement, 33 (32%) followed one or
more CSF shunt revisions. Baseline factors independently associated with risk of first infection included: gastro-
stomy tube (HR 2.0, 95% CI, 1.1, 3.3), age 6-12 months (HR 0.3, 95% CI, 0.1, 0.8), and prior neurosurgery (HR
0.4, 95% CI, 0.2, 0.9). After controlling for baseline factors, infection risk was most significantly associated with
the need for revision (1 revision vs none, HR 3.9, 95% CI, 2.2, 6.5; $2 revisions, HR 13.0, 95% CI, 6.5, 24.9).
Conclusions This study quantifies the elevated risk of infection associated with shunt revisions observed in clinicalFrom the 1Department of Pediatrics, University of
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A
lthough placement of cerebrospinal fluid (CSF) shunts successfully treats
hydrocephalus, it also frequently leads to new medical and surgical prob-
lems. CSF shunt failure is common and necessitates subsequent CSF shunt
revision surgery.1-3 CSF shunt infections are a substantial problem for children
with hydrocephalus, their parents, and their caregivers. Infections number up to
2400 admissions and 59 000 hospital days each year in the US.4 Despite aggressive
treatment that typically involves 2 surgeries as well as a prolonged inpatient stay to
receive intravenous antibiotics,5 per patient reinfection rates are high at 20%-
25%.6,7
Because of the high morbidity associated with CSF shunt infection, it is critical
for families and care providers to understand whether certain children undergo-
ing CSF shunt placement are at highest risk for subsequent infection. The asso-
ciation of both patient risk factors and factors at the time of initial CSF shunt
placement with first CSF shunt infection is complicated when intervening CSF
shunt revisions are required. In addition, risk of infection is not constant,
declining with time following a revision.8 Interval CSF shunt revision(s)9 and
previous infection6,7,10 have been associated with increased odds of infection.
However, the relative contribution of each intervening revision surgery, and its
relationship to baseline risk of infection for a given child, was elucidated only
recently in a study that assembled a large and detailed retrospective cohort of
children at a single center undergoing initial CSF shunt placement. Young agetional Center for Research Resources or National Insti-
tutes of Health. The authors declare no conflicts of
interest.
0022-3476 ª 2014 The Authors. Published by
Elsevier Inc.
http://dx.doi.org/10.1016/j.jpeds.2014.02.013
CSF Cerebrospinal fluid
EVD External ventricular drain
HCRN Hydrocephalus Clinical Research Network
HR Hazard ratio
1462
Open access under CC BY-NC-ND license.
Vol. 164, No. 6  June 2014and intervening revision procedures were found to be associ-
ated with infection risk, and underlying condition of myelo-
meningocele demonstrated a protective effect.11 However,
this study was limited by its retrospective design and conduct
at a single center.11
The object of this study was to quantify the extent to which
CSF shunt revision(s) are associated with increased risk of CSF
shunt infection, after adjusting for patient factors that may
contribute to infection risk, in a large current multicenter pro-
spective cohort of patients undergoing initial CSF shunt place-
ment. We also considered the surgeon as well as medical and
surgical decisions at the time of last surgery (either initial shunt
placement or revision surgery) as potential confounders.Methods
The Hydrocephalus Clinical Research Network (HCRN) is a
collaboration of pediatric neurosurgical centers conducting
systematic investigations in the management of pediatric hy-
drocephalus.12-14 The HCRN has maintained a registry with
prospectively collected data about neurosurgical procedures
at seven centers across North America that first started in
2008. The 7 hospitals contributing to the HCRN registry
include Children’s Hospital of Alabama and University of
Alabama, Children’s Hospital of Pittsburgh, Hospital for
Sick Children, Primary Children’s Medical Center, Seattle
Children’s Hospital, Texas Children’s Hospital, and St. Louis
Children’s Hospital/Washington University; all except Chil-
dren’s Hospital of Pittsburgh contributed data to this study.
The HCRN Data Coordinating Center is housed in Salt Lake
City. Use of HCRN registry data was approved by the HCRN
and the Institutional Review Boards at the University of Utah
and Seattle Children’s Hospital.
The HCRN enrolls all children less than 18 years of age in
the network registry who receive care at any of the network
hospitals and who undergo CSF shunt surgery. Data collec-
tion started in April 2008 and, for this study, ended for all
procedures occurring on or before December 31, 2011. We
assembled a final prospective cohort of 1036 children whose
initial CSF shunt placement was recorded in the HCRN reg-
istry during the study period. All children in the cohort un-
derwent initial CSF shunt placement, and additionally may
have undergone CSF shunt revision(s) and/or infection prior
to the end of the study period (Figure 1; available at www.
jpeds.com).
Within the HCRN registry, data from each neurosurgical
admission for each cohort member is collected prospectively.
Each member was followed for infection until the end of
study follow-up on December 31, 2011, and participants
were censored prior to the end of follow-up in the event of
death (n = 50), a move out of the network (n = 34), or shunt
removal (n = 12). The date a child developed infection, died,
moved, or had their CSF shunt removed was the date of
censoring. If the date of death was not available (n = 5), we
used day after last procedure in registry as censoring date.
No patient withdrew consent during the follow-up period.Primary Outcome Variable
First CSF shunt infection was defined by either microbio-
logical determination of presence of bacteria in a culture
or Gram stain of CSF, wound swab, and/or pseudocyst
fluid or shunt erosion (visible hardware) or abdominal
pseudocyst (even without positive culture). For children
with ventriculoatrial shunts, presence of bacteria in a
blood culture was diagnostic of infection. This definition
of CSF shunt infection was previously developed by
consensus among HCRN neurosurgeons.11,12,15 The first
CSF sample for diagnosis of infection usually was obtained
from needle aspiration of the shunt reservoir under sterile
conditions outside the operating room at a bedside “shunt
tap,” usually prior to the initiation of antibiotic treatment.
In all other neurosurgical admissions that involved 2 CSF
shunt surgeries (such as removal and external ventricular
drain [EVD] placement followed by new shunt placement)
as well as 48 hours or more of intravenous antibiotic treat-
ment, author T.S. and the local research coordinator re-
viewed the case in detail to review whether cases met
infection criteria.
Predictor Variable
The main predictor variable of interest was CSF shunt revi-
sion, defined as an operative neurosurgical interventional
procedure performed on the CSF shunt. In cases where a
staged revision was performed in 2 or more procedures
(such as externalization of a shunt followed several days later
by re-internalization), the staged revision was handled as a
single event and tested as an independent risk factor for infec-
tion. The time period between staged procedures was consid-
ered noncontributory to infection risk, and details of medical
and surgical decisions at the time of only the last neurosur-
gical procedure were considered in analyses. Any surgical
procedure associated with infection treatment was consid-
ered the first CSF shunt infection rather than CSF shunt re-
visions for this study.
Potential Confounding Variables
Potential confounding factors included patient risk factors
such as demographics, risk factors prior to initial CSF shunt
placement, and risk factors at the time of CSF shunt place-
ment as shown in Table I and Figure 1. Prior
neurosurgeries included endoscopic third ventriculostomy
and/or subgaleal and/or reservoir as determined by chart
review; and complex chronic conditions were classified as
previously described.4
In addition to revision procedures and patient factors, we
also report the association of surgeon factors and medical
and surgical decisions at preceding CSF shunt surgeries
(initial CSF shunt placement and/or CSF shunt revision)
with CSF shunt infection. Surgeon factors include attending
surgeon factors (including surgeon, surgeon’s experience
defined as years since fellowship, surgeon’s volume as num-
ber of initial CSF shunt placements per year) and resident
surgeon factors (month of year reflecting their experience).
Medical and surgical decisions we considered are those1463
Table I. Characteristics of the study cohort
Prospective cohort
(n = 1036)
Demographics
Sex, n (%)
Male 582 (56%)
Female 454 (44%)
Race, n (%)
White 655 (63%)
Other/unknown 199 (19%)
African American 152 (15%)
Asian 20 (2%)
AI/AN/NH/PI 10 (1%)
Insurance status, n (%)
Public (Medicaid, Medicare) 423 (41%)
Private 409 (39%)
Self-pay 36 (4%)
Other (eg, military) 21 (2%)
Government 147 (14%)
Risk factors prior to initial surgery
Birth weight (kg),* median (IQR) 3.0 (1.6, 3.4)
Gestational age (wk),* median (IQR) 37 (31, 40)
Length of hospitalization preceding initial
shunt placement (d),* median (IQR)
2 (0, 14)
Prior neurosurgery, n (%) 131 (13%)
Risk factors at initial CSF placement
Chronologic age, n (%)
0 to <6 mo 577 (56%)
6 to <12 mo 110 (11%)
1 to <2 y 71 (7%)
2 to <9 y 165 (16%)
9-18 y 113 (11%)
Indication for shunt placement, n (%)
Post-IVH due to prematurity 226 (22%)
Myelomeningocele 164 (16%)
Posterior fossa tumor 109 (11%)
Aqueductal stenosis 84 (8%)
Communicating congenital 80 (8%)
Supratentorial tumor 67 (6%)
Posthead injury 49 (5%)
Other intracranial cyst 44 (4%)
Posterior fossa cyst 40 (4%)
Spontaneous ICH/IVH/SAH 39 (4%)
Post-infectious 38 (4%)
Other 34 (3%)
Other congenital 20 (2%)
Midbrain tumor/lesion 16 (2%)
Encephalocele 15 (1%)
Craniosynostosis 11 (1%)
Weight at surgery (kg), median (IQR) 6.0 (3.3, 13.4)
CCCs, n (%)
None (excepting hydrocephalus) 727 (70%)
One 247 (24%)
Two or more 62 (6%)
Gastrostomy, n (%) 100 (10%)
Tracheostomy, n (%) 29 (3%)
CSF shunt procedure(s) within 12 mo, n (%)
One CSF shunt revision 166 (16%)
Two or more CSF shunt revisions 99 (10%)
CSF shunt infection 102 (10%)
AI/AN/NH/PI, American Indian/Alaska Native/ Native Hawaiian/Pacific Islander; CCC, complex
chronic condition; ICH, intracerebral hemorrhage; IVH, intraventricular hemorrhage; SAH, sub-
arachnoid hemorrhage.
*Data was available for birthweight among 689 children, gestational age and postconceptional
age for 908 children, and length of stay for 983 children.
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proximal shunt location was designated when 2 or more
catheters were present, and distal shunt location included
peritoneal, atrial, and other.1464Statistical Analyses
Cohort characteristics at baseline were summarized overall
and by subsequent infection status. Binary and categorical
variables were described using frequencies and percents,
and continuous variables were described using means and
SDs or medians and IQRs for duration of follow-up, time
to infection, and other skewed variables. Univariate survival
analyses were performed to test the associations of each
cohort characteristic with infection.
Similarly, the associations of surgeon factors and medical
and surgical decisions at preceding CSF shunt surgeries
with CSF shunt infection were described using hazard ratios
(HRs), a type of rate ratio estimate, and 95% profile likeli-
hood CI. Cox proportional hazard models were used to
calculate HR and to test for the association between CSF
shunt revision(s) and first CSF shunt infection while control-
ling for possible confounding baseline characteristics.16,17
CSF shunt revision(s) were categorized as none, 1, and 2 or
more; and were treated as a time-dependent covariate,
because an individual child’s revision status could change
during the study period. For each day on which an infection
occurred, this time-dependentmodel compared the infection
hazard among children who had not experienced a shunt
revision to date with those who had experienced 1 or 2 or
more.
Baseline characteristics included a priori in the multivari-
able model were age, sex, and indication for shunt placement.
Additional baseline characteristics shown in Table I were
evaluated for inclusion in the model using stepwise
regression methodology.18,19 Using this approach, the
model is initiated with a forward selection step in which a
single variable is added to the model, and each forward
selection step may be followed by one or more backward
elimination steps in each of which a single variable may be
removed from the model.20 Criterion for entry into the
model was P # .05; criterion for removal from the model
was P > .05. Strict criteria were used to reduce error
associated with multiple testing and identification of
nonsignificant correlated risk factors in the multivariable
regression. The HRs from the final multivariable models
are presented with 95% profile likelihood CIs.
Sensitivity analyses were performed to investigate whether
surgeon factors and medical and surgical decisions (either at
initial placement or revision) may mediate the relationship
between revisions and infection. We decided a priori to test
factors of most interest, which included antibiotic impreg-
nated shunt tubing use, nonperitoneal distal shunt location,
complex shunt, staged revision, neuroendoscope use, and ul-
trasound use, as well as surgeon experience as it was signifi-
cant in univariate analysis. These factors were evaluated in
the final multivariable model as an additional time-
dependent factor to determine whether the association be-
tween revisions and infections was altered by inclusion of
these additional factors. In additional sensitivity analyses,
we also considered site as a main effect and tested models
without prior neurosurgery because of its association with
intraventricular hemorrhage in this dataset.Simon et al
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tute, Cary, North Carolina).Results
Baseline patient-level risk factors for the 1036 children in the
cohort are shown in Table I. The cohort had a median age
of 19 weeks (IQR 4, 123), and indication for CSF shunt
placement was distributed between postintraventricular
hemorrhage because of prematurity (22%), myelom-
eningocele (16%), posterior fossa tumor (11%), aqueductal
stenosis (8%), and other etiologies. Overall 112 (11%)
children developed first CSF shunt infection. The majority
(102, 91%) of first CSF shunt infection occurred within 12
months of initial placement. During the same time period,
CSF shunt revisions occurred in 265 (26%) of the entire
cohort and 33 (32%) of those who developed infection. The
median duration of follow-up from initial CSF shunt
placement in the uncensored cohort was 592 days (IQR 272,
892).
Many infection prevention practices were standardized
within the network,12 including use of prophylactic antibi-
otics intravenously and intrathecally (data not shown). How-
ever, we did observe differences between sites in some
surgical practices, such as in type of shunt brand and use of
neuroendoscope and ultrasound (data not shown).
There were 112 (11%) children who developed infection
over the course of the entire study.Table II presents the
baseline patient-level risk factors by infection status, as
well as unadjusted associations with risk of CSF shunt
infection. In univariate survival analyses, factors that
demonstrated a significant association with infection risk
included self-pay insurance, cardiac complex chronic
condition, presence of a gastrostomy tube, and
subsequent CSF shunt revisions. Older gestational age was
associated with less infection risk.Association between Revisions and Infection Risk
Our multivariable model of infection risk demonstrates the
HRs for first CSF shunt infection for each of the explanatory
variables while controlling for the other explanatory vari-
ables (Table III). Gastrostomy tube at initial CSF shunt
placement (HR 2.0, 95% CI, 1.1, 3.3) was significantly
associated with an increased risk of infection, and age 6-
12 months (HR 0.3, 95% CI, 0.1, 0.8) and prior
neurosurgery (HR 0.4, 95% CI, 0.2, 0.9) were significantly
associated with a decreased risk of infection. When age
was handled as a continuous variable, it was not
associated with infection.
Infection risk was significantly related to revision after
controlling for age, sex, and indication for shunt placement.
Infection risk was more than 3 times greater among those
with a revision compared with those without a revision
(HR 3.9, 95% CI, 2.2, 6.5), and the risk was 13 times greater
among those with 2 or more revisions compared with none
(HR 13.0, 95% CI, 6.5, 24.9).Risk Factors for First Cerebrospinal Fluid Shunt Infection: FindingSensitivity Analyses
Sensitivity analyses were performed to determine whether the
association between revisions and infections were
confounded by surgeon factors and medical and surgical de-
cisions. Only a few surgeon factors, medical and surgical de-
cisions at the preceding surgeries (initial CSF shunt
placement and/or CSF shunt revision), were associated
with infection hazard in univariate survival analysis; these
included less surgeon experience (lower risk) and complex
shunt (higher risk) (Figure 2). Medical and surgical
decisions of interest, as well as surgeon’s experience, were
added to the multivariable Cox proportional hazards
model in Table III to evaluate whether the association
between revisions and infection remained significant.
Surgeon experience for those under 5 years remained
independently significant with HR 0.5 (95% CI, 0.2, 0.8);
however, its addition did not change the HR estimates or
significance for revisions substantially. None of the other
medical and surgical factors of interest, nor inclusion of
site, either demonstrated a significant association with
infection hazard or changed the HR estimates or
significance for revisions. Exclusion of prior neurosurgery
changed the HR estimates for other variables only by
making gastrostomy insignificant.
Discussion
In this large prospective multicenter cohort of children un-
dergoing initial CSF shunt placement, 11% developed a first
CSF shunt infection. We developed robust models that quan-
tified the relative contributions to the risk of infection of
baseline patient factors (including indication for CSF shunt
placement) as well as each revision surgery. Baseline patient
factors independently associated with first infection included
presence of a gastrostomy tube (increased risk) and prior
neurosurgery (decreased risk). However, it is revision sur-
geries that are most significantly associated with infection
risk, and this risk increased dramatically with subsequent re-
visions. Surgeon, site, and medical and surgical decisions
involved in shunt surgeries, both at initial placement and
revision surgery, did not alter the relationship between revi-
sions and infection. This study decisively quantifies this dra-
matic and clinically important risk of infection associated
with revisions that has been observed in clinical practice.
This study augments a similar analysis performed in a single
center retrospective cohort.11 In the current study, we found
that shunt placement at 6-12 months of age was protective. In
our previous work, age 0 to <6months at CSF shunt placement
was significantly associated with an increased risk of infection
(HR 2.4, 95% CI, 1.02, 6.7). The association of age with infec-
tion risk appears as inconsistent across ours and other
studies.21,22
In this larger study, we found that presence of a gastro-
stomy tube was associated with infection risk. We did not
assess gastrostomy risk in our previous analysis. Physically,
it makes some sense that the presence of a gastrostomy
tube could confer infection risk when a ventriculoperitoneals from a Multi-Center Prospective Cohort Study 1465
Table II. Association of characteristics in the cohort with first CSF shunt infection
First CSF shunt Infection (n = 112) No CSF shunt infection (n = 924) Unadjusted HR (95% CI)*
Demographics
Sex, n (%)
Male 61 (54%) 521 (56%) 0.9 (0.6, 1.3)
Female 51 (46%) 403 (44%) Referent
Race, n (%)
White 65 (58%) 590 (64%) Referent
Other/unknown 23 (21%) 176 (19%) 1.2 (0.8, 2.0)
African American 22 (20%) 130 (14%) 1.5 (0.9, 2.3)
Asian 1 (1%) 19 (3%) 0.5 (0.0, 2.3)
AI/AN/NH/PI 1 (1%) 9 (1%) 1.0 (0.1, 4.3)
Ethnicity, n (%)
Latino 18 (16%) 127 (14%) 1.3 (0.7, 2.0)
Not Latino 72 (64%) 629 (68%) Referent
Unknown 22 (20%) 168 (18%) 1.2 (0.7, 1.8)
Insurance status, n (%)
Public (Medicaid, Medicare) 46 (41%) 377 (41%) 1.1 (0.7, 1.8)
Private 39 (35%) 370 (40%) Referent
Self-pay 9 (8%) 27 (3%) 2.9 (1.3, 5.6)
Other (eg, military) 2 (2%) 19 (2%) 1.1 (0.2, 3.5)
Government 16 (14%) 131 (14%) 1.2 (0.7, 2.1)
Risk factors prior to initial surgery
Birth weight (kg), median (IQR) 2.7 (1.0, 3.2) 3.0 (1.7, 3.4) 0.8 (0.7, 1.02)
Gestational age (wk), median (IQR) 36 (26, 39) 38 (32, 40) 0.95 (0.92, 0.98)
Length of hospitalization preceding initial
shunt placement (d), median (IQR)
4 (1, 21) 2 (0, 14) 1.0 (0.99, 1.01)
Prior surgery (neurosurgical), n (%) 13 (12%) 118 (13%) 0.9 (0.5, 1.6)
Risk factors at initial CSF placement
Chronologic age, n (%)
0 to <6 mo 73 (65%) 504 (55%) 1.0 (0.6, 2.0)
6 to <12 mo 10 (9%) 100 (11%) 0.7 (0.3, 1.6)
1 to <2 y 7 (6%) 64 (7%) 1.4 (0.6, 3.1)
2 to <9 y 10 (9%) 155 (17%) 0.7 (0.3, 1.5)
9 to 18 y 12 (11%) 101 (11%) Referent
Postconceptional age (wk), median (IQR) 2 (-3, 31) 9 (-1, 70) 1.0 (0.99, 1.01)
Indication for shunt placement, n (%)
Post-IVH due to prematurity 36 (32%) 190 (21%) 1.5 (0.8, 3.4)
Tumor (posterior fossa, supratentorial, midbrain) 15 (13%) 177 (19%) 0.8 (0.3, 1.9)
Myelomeningocele 15 (13%) 149 (16%) 0.8 (0.4, 1.9)
Congenital (communicating, other, encephalocele,
craniosynostosis)
13 (12%) 113 (12%) 0.9 (0.4, 2.2)
Cyst (posterior fossa, intracranial) 12 (11%) 72 (8%) 1.4 (0.6, 3.4)
Aqueductal stenosis 9 (8%) 75 (8%) Referent
Posthead injury 5 (4%) 44 (5%) 0.9 (0.3, 2.7)
Spontaneous ICH/IVH/SAH 2 (2%) 37 (4%) 0.5 (0.1, 2.0)
Postinfectious 3 (3%) 35 (4%) 0.7 (0.2, 2.3)
Other 2 (2%) 32 (3%) 0.5 (0.1, 2.0)
Weight at surgery (kg), median (IQR) 4.1 (2.9, 9.7) 6.3 (3.4, 13.9) 1.0 (0.99, 1.01)
CCCs, n (%)
None (excepting hydrocephalus) 72 (64%) 655 (71%) Referent
One 30 (27%) 217 (23%) 1.3 (0.8, 1.9)
Two or more 10 (9%) 52 (6%) 1.8 (0.9, 3.3)
Neuromuscular CCC, n (%) 15 (13%) 100 (11%) 1.3 (0.7, 2.1)
Cardiac CCC, n (%) 14 (13%) 69 (7%) 1.9 (1.1, 3.3)
Respiratory CCC, n (%) 11 (10%) 78 (8%) 1.2 (0.6, 2.1)
Renal CCC, n (%) 2 (2%) 7 (1%) 2.1 (0.3, 6.6)
Gastrointestinal CCC, n (%) 4 (4%) 12 (1%) 2.4 (0.7, 5.8)
Hematologic CCC, n (%) 0 (0%) 1 (0%) n/a
Metabolic CCC, n (%) 2 (2%) 5 (1%) 2.8 (0.5, 8.7)
Congenital/genetic CCC, n (%) 6 (5%) 44 (5%) 1.2 (0.5, 2.4)
Malignancy CCC, n (%) 1 (1%) 26 (3%) 0.3 (0.0, 1.4)
Gastrostomy, n (%) 19 (17%) 81 (9%) 2.0 (1.2, 3.2)
Tracheostomy, n (%) 5 (4%) 24 (3%) 1.7 (0.6, 3.7)
CSF shunt revision(s) within 12 mo, n (%)
No CSF shunt revisions 79 (71%) 692 (75%) Referent
One CSF shunt revision 19 (17%) 147 (16%) 3.6 (2.1, 5.9)
Two or more CSF shunt revisions 14 (12%) 85 (9%) 11.9 (6.1, 21.6)
n/a, not applicable.
Bolded values are stastically significant.
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Table III. Results from multivariable Cox proportional
hazard model for the association between revisions and
first CSF shunt infection, adjusting for baseline
characteristics and confounders*
Adjusted HR (95% CI)
Revision procedure
2 or more 13.0 (6.5, 24.9)
1 3.9 (2.2, 6.4)
None Referent
Chronologic age at initial shunt placement
0 to <6 mo 0.7 (0.3, 1.7)
6 to <12 mo 0.3 (0.1, 0.8)
1 to <2 y 0.8 (0.3, 1.9)
2 to <9 y 0.6 (0.2, 1.3)
9 to 18 y Referent
Female sex 1.1 (0.8, 1.7)
Indication for initial shunt placement
Myelomeningocele 0.7 (0.3, 1.8)
Post-IVH due to prematurity 1.9 (0.9, 4.2)
Posthead injury 0.7 (0.2, 2.2)
Tumor (posterior fossa, midbrain,
supratentorial)
0.7 (0.3, 1.8)
Cyst (other intracranial, posterior fossa) 1.6 (0.7, 3.9)
Spontaneous ICH/IVH/SAH 0.5 (0.1, 2.0)
Postinfectious 0.6 (0.1, 1.9)
Congenital (communicating, other,
encephalocele, craniosynostosis)
0.9 (0.4, 2.2)
Other 0.5 (0.1, 2.4)
Aqueductal stenosis Referent
Gastrostomy tube 2.0 (1.1, 3.3)
Prior neurosurgery 0.4 (0.2, 0.9)
Bolded values are stastically significant.
*Baseline characteristics included a priori were age, sex, and indication for shunt placement.
Additional baseline characteristics shown in Table I were evaluated for inclusion in the model
using stepwise regression methodology. Criterion for entry into the model was P # .05;
criterion for removal from the model was P > .05.
June 2014 ORIGINAL ARTICLESshunt is present. However, it may also be a marker for med-
ical complexity. Unfortunately, we do not have data on the
timing of gastrostomy tube placement in this cohort, limiting
our ability to understand the nature of its timing with infec-
tion risk. Presence of a gastrostomy tube represents an
important risk factor to consider in clinical practice as well
as future studies.
In the current study, we found that prior neurosurgery was
protective. Although we considered prior neurosurgery in
previous work and it was not associated with infection, it
was assessed from International Classification of Disease,
Ninth Revision, Clinical Modification codes rather than chart
review and, unlike this study, included consideration of
EVDs. In our previous work, myelomeningocele was signifi-
cantly associated with a decreased risk of infection (HR 0.4,
95% CI, 0.2, 0.8); we wondered if the routine use of exposure
to antibiotics intravenously seen in children with myelome-
ningocele might explain the protective effect in the single
center study. The protective effect of myelomeningocele
was not replicated in this larger cohort. One possible expla-
nation for the protective effect of prior neurosurgery in this
study, which we did not test, again could be prior exposure
to antibiotics intravenously.
None of the associations of baseline factors in this or the
previous study was as strong as performance of CSF shunt
revision. Taking both studies together, 1 CSF shunt revisionRisk Factors for First Cerebrospinal Fluid Shunt Infection: Findingwas associated with 3- to 4-fold higher hazard of infection
whereas 2 or more CSF shunt revisions were associated
with 6- to 13-fold higher infection hazard. Our finding of
each subsequent CSF shunt revision increasing infection
risk for a patient also is consistent with previous work.9
Each surgery likely represents an opportunity to introduce
new organisms into the CSF and onto shunt hardware.
Each surgical exposure of the shunt apparatus may represent
an opportunity to further colonize a shunt apparatus in a
sterile setting, with an additive effect over time. Future
research efforts should focus on modalities to reduce micro-
bial exposure during the perioperative period to optimize
revision procedures and reduce risk of subsequent infection.
Conclusions about medical and surgical decisions, as well
as surgeon’s volumes and experience, can be limited as they
vary between and are highly confounded by surgeon and
study site.23 However, many medical and surgical decisions
to prevent infection, including prophylactic use of antibi-
otics,24,25 site preparation including hair clipping,26,27 type
of skin cleanser,26,28 double gloving,25 prophylactic intraven-
tricular antibiotic use,28-31 and use of a wound dressing were
standardized within the HCRN.12 By reducing background
variation, this standardization permitted us to more
concisely address baseline risk factors associated with infec-
tion risk. Areas of ongoing controversy in the prevention of
CSF shunt infection include use of antibiotic impregnated
shunt tubing,32-35 distal shunt location,22,36-40 and use of
neuroendoscope.10,25 In this study, surgeon, study site, or
medical and surgical decision did not substantially
contribute to infection risk beyond CSF shunt revision itself.
This work has several limitations. The conduct of this
study at a group of centers adhering to a common checklist
of medical and surgical practices to prevent shunt infection
reduces generalizability of findings outside of the HCRN.
The small number of surgeons and hospitals limits the ability
to systematically study surgeon and hospital effects on pa-
tient outcome. However, the multi-institutional nature of
this study gives it greater generalizability than previous
studies. Certain patient risk factors may not have been
captured in this analysis. Missing data on gestational age
and birth weight limits our ability to draw conclusions about
these patient factors, and we did not collect data on use of
antibiotic-impregnated EVD or postoperative wound care
practices. Outcomes were all collected passively. Our defini-
tion of infection was developed by consensus within the
HCRN and does not permit easy comparison with infection
rates at non-HCRN sites or those used by hospital infection
control groups. For neurosurgical procedures, the assump-
tion is that patients return to the same center for care. Death
as an outcome depends on the neurosurgical center staff
knowledge of a child’s demise. If children moved to a
different location, they were lost to follow-up.
Families of and care providers for children with recurrent
CSF shunt revisions should be aware of their increased odds
of CSF shunt infection. Further research is needed to opti-
mize strategies for revision procedures and to reduce risk
of subsequent infection. ns from a Multi-Center Prospective Cohort Study 1467
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Appendix
Additional members of HCRN include:
Amita Bey, MPH (Children’s Hospital of Alabama and
University of Alabama); Arlene Luther, BS, RN (Children’s
Hospital of Pittsburgh); Lindsay O’Connor, MSc and Megha
Agrawal (Hospital for Sick Children); Tracey Habrock-Bach,
BS (Primary Children’s Medical Center); Amy Anderson,
BSN, RN (Seattle Children’s Hospital); Sheila Ryan, MPH,
JD (Texas Children’s Hospital); and Deanna Mercer (Wash-
ington University).
HCRNData Coordinating Center: Nichol Nunn, BS, MBA
and Jeff Yearley, BA (University of Utah, Salt Lake City,
Utah).
HCRN Data Coordinating Center Statistical Staff: Mi-
chelle Miskin, MS and Lydia Dong, MS (University of
Utah, Salt Lake City, Utah).
Collaborating HCRN investigator: Chevis N. Shannon,
PhD (Children’s Hospital of Alabama and University of Ala-
bama during study period, now Department of Neurosur-
gery, Vanderbilt University).
Figure 1. Timeline of events for each patient in cohort. Shading indicates event did not occur for all children.
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Figure 2. Association of surgeon, medical, and surgical characteristics in the cohort with first CSF shunt infection in univariate
survival analyses. *Significant in univariate survival analysis. IV, intravenous; IT, intrathecal.
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